Pelage Pharmaceuticals, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: AWAKENING · PP405 in Adult Females With Androgenetic Alopecia Recruitment opened
- Minor: AWAKEN · PP405 in Adult Males Trial sites expanded: 22 → 63 locations
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-30 | NCT07907783 Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia | Phase 2 | Recruiting |
Active trials by phase
| Phase 2 | 1 | |
| Phase 2/3 | 1 |
Get alerts when Pelage Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.